Stay updated on Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2Fb3GT9qJbNcJrwwHFsFfY1HfqBq4.uncropped.jpg&w=3840&q=75)
Latest updates to the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page
- ChecktodayNo Change Detected
- CheckyesterdayNo Change Detected
- Check2 days agoNo Change Detected
- Check4 days agoNo Change Detected
- Check5 days agoChange DetectedThe study has expanded to include 143 locations and has been updated from revision v2.9.7 to v2.10.0.SummaryDifference0.2%
- Check11 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.0%
- Check23 days agoChange DetectedThe website has been updated to Revision v2.9.6 from v2.9.5.SummaryDifference0.0%
- Check30 days agoChange DetectedThe value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent change in the webpage content.SummaryDifference0.0%
- Check31 days agoChange DetectedThe value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent revision in the content of the webpage.SummaryDifference0.0%
- Check32 days agoChange DetectedThe value 'Show more Revision: v2.9.0' has been updated to 'MedlinePlus related topics: Thyroid Cancer, Thyroid Diseases, Genetic and Rare Diseases Information Center resources: Thyroid Cancer, Medullary Neuroendocrine Tumor, Neuroepithelioma, Drug Information available for: Thyroid, Vandetanib, Cabozantinib, Selpercatinib, FDA Drug and Device Resources'SummaryDifference40%
Stay in the know with updates to Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page.